Economic Costs of Adverse Drug Reactions M. N. Graham Dukes Guest Editorial 13 November 2012 Pages: 153 - 154
Indices of Therapeutic Outcome in Pharmacoeconomic Evaluation of Drug Therapy Susan F. Hurley Leading Article 13 November 2012 Pages: 155 - 160
Erratum to: Economic Evaluation of Pharmaceuticals Michael F. Drummond Erratum 13 November 2012 Pages: 160 - 160
The Pharmacoeconomics of HIV Disease Lorna A. LynnKevin A. SchulmanJohn M. Eisenberg Review Article 13 November 2012 Pages: 161 - 174
Costs, Benefits and Unintended Gastrointestinal Side Effects of Pharmaceutical Therapy Bernard S. Bloom Review Article 13 November 2012 Pages: 175 - 181
Selection of Items and Avoidance of Bias in Quality of Life Scales Michael E. Hyland Review Article 13 November 2012 Pages: 182 - 190
A Review of Limited Lists and Formularies Malcolm J. PearceEvan J. Begg Review Article 13 November 2012 Pages: 191 - 202
Utilisation of Psychotropic Drugs in Patients of the Long Stay Ward Fatma El HefnyM. K. Al HaddadVijay Mathur Original Research Article 13 November 2012 Pages: 203 - 206
The Economics of an Intensive Education Programme for Asthmatic Patients Birthe SøndergaardFlemming DavidsenHenrik Hey Original Research Article 13 November 2012 Pages: 207 - 212
Cost-Effectiveness of Simvastatin Versus Cholestyramine Krister HjalteBjörn LindgrenUlf Persson Original Research Article 13 November 2012 Pages: 213 - 216
Payment Restrictions for Prescription Drugs under Medicaid Richard M. SchulzNancy J. W. Lewis Current Comment 13 November 2012 Pages: 217 - 219
Opportunities to Improve the Cost-Effectiveness of Treatment for Hypertension B. N. C. Prichard Current Comment 13 November 2012 Pages: 219 - 221
